<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) is the second most common dementing illness </plain></SENT>
<SENT sid="1" pm="."><plain>We have recently reported that <z:mp ids='MP_0002055'>diabetes</z:mp> induces VaD in rats </plain></SENT>
<SENT sid="2" pm="."><plain>The present study has been designed to investigate the potential of peroxisome-proliferator-activated receptors-gamma (PPAR-γ) <z:chebi fb="4" ids="48705">agonists</z:chebi> in <z:mp ids='MP_0002055'>diabetes</z:mp> induced VaD of Wistar <z:mp ids='MP_0001189'>Albino</z:mp> rats </plain></SENT>
<SENT sid="3" pm="."><plain>The rats were administered, single dose of <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> (STZ) for the induction of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001465'>Morris water-maze</z:mp> (MWM) test was employed for testing learning and memory </plain></SENT>
<SENT sid="5" pm="."><plain>Serum <z:chebi fb="105" ids="17234">glucose</z:chebi>, bodyweight, vascular endothelial function, serum <z:chebi fb="95" ids="16301">nitrite</z:chebi>/nitrate levels, aortic and brain <z:mp ids='MP_0003674'>oxidative stress</z:mp> levels (viz. aortic <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> levels, brain <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi> reactive species and brain <z:chebi fb="0" ids="16856">glutathione</z:chebi> levels) and brain acetylcholinesterase activity were also tested </plain></SENT>
<SENT sid="6" pm="."><plain>STZ treated animals performed poorly on MWM hence reflecting impairment of learning and memory behavior with a significant reduction in body weight, impairment of vascular endothelial function, and decrease in serum <z:chebi fb="95" ids="16301">nitrite</z:chebi>/nitrate levels, increase in serum <z:chebi fb="105" ids="17234">glucose</z:chebi>, aortic and brain <z:mp ids='MP_0003674'>oxidative stress</z:mp> levels and brain acetylcholinesterase activity </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment of PPAR-γ <z:chebi fb="4" ids="48705">agonists</z:chebi>, <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> as well as <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> significantly reversed, <z:mp ids='MP_0002055'>diabetes</z:mp> induced impairment of learning and memory behavior, endothelial function, and changes in various biochemical parameters </plain></SENT>
<SENT sid="8" pm="."><plain>It is concluded that PPAR-γ modulators <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> and <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> may be considered as potential pharmacological agents for the management of <z:mp ids='MP_0002055'>diabetes</z:mp> induced VaD </plain></SENT>
</text></document>